Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Systemic lupus erythematosus | D008180 | HP_0002725 | M32 | 1 | 1 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | 1 | — | — | — | — | 1 |
Arthritis | D001168 | HP_0001369 | M05-M14 | 1 | — | — | — | — | 1 |
Drug common name | ROZIBAFUSP ALFA |
INN | rozibafusp alfa |
Description | Rozibafusp alfa is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | fusion proteins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4650245 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | O9YF5SN7KL (ChemIDplus, GSRS) |